649 related articles for article (PubMed ID: 28642697)
1. Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.
Subramaniam SR; Federoff HJ
Front Aging Neurosci; 2017; 9():176. PubMed ID: 28642697
[TBL] [Abstract][Full Text] [Related]
2. Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.
L'Episcopo F; Tirolo C; Serapide MF; Caniglia S; Testa N; Leggio L; Vivarelli S; Iraci N; Pluchino S; Marchetti B
Front Aging Neurosci; 2018; 10():12. PubMed ID: 29483868
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
[TBL] [Abstract][Full Text] [Related]
6. Natural products as a potential modulator of microglial polarization in neurodegenerative diseases.
Jin X; Liu MY; Zhang DF; Zhong X; Du K; Qian P; Gao H; Wei MJ
Pharmacol Res; 2019 Jul; 145():104253. PubMed ID: 31059788
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
[TBL] [Abstract][Full Text] [Related]
8. Microglia Mediated Neuroinflammation in Parkinson's Disease.
Isik S; Yeman Kiyak B; Akbayir R; Seyhali R; Arpaci T
Cells; 2023 Mar; 12(7):. PubMed ID: 37048085
[TBL] [Abstract][Full Text] [Related]
9. Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson's disease.
Du RH; Sun HB; Hu ZL; Lu M; Ding JH; Hu G
Cell Death Dis; 2018 Mar; 9(3):404. PubMed ID: 29540778
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.
de Almeida EJR; Ibrahim HJ; Chitolina Schetinger MR; de Andrade CM; Cardoso AM
Neurochem Res; 2022 Nov; 47(11):3221-3240. PubMed ID: 35962936
[TBL] [Abstract][Full Text] [Related]
11. Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.
Du L; Zhang Y; Chen Y; Zhu J; Yang Y; Zhang HL
Mol Neurobiol; 2017 Dec; 54(10):7567-7584. PubMed ID: 27830532
[TBL] [Abstract][Full Text] [Related]
12. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
13. Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset Parkinsonism.
Porrini V; Mota M; Parrella E; Bellucci A; Benarese M; Faggi L; Tonin P; Spano PF; Pizzi M
Front Aging Neurosci; 2017; 9():229. PubMed ID: 28769786
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming and polarization of microglia in Parkinson's disease: Role of inflammasome and iron.
Yu H; Chang Q; Sun T; He X; Wen L; An J; Feng J; Zhao Y
Ageing Res Rev; 2023 Sep; 90():102032. PubMed ID: 37572760
[TBL] [Abstract][Full Text] [Related]
15. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
[TBL] [Abstract][Full Text] [Related]
17. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease.
Zhang Y; Feng S; Nie K; Li Y; Gao Y; Gan R; Wang L; Li B; Sun X; Wang L; Zhang Y
Biochem Biophys Res Commun; 2018 May; 499(4):797-802. PubMed ID: 29621548
[TBL] [Abstract][Full Text] [Related]
18. The role of the M1/M2 microglia in the process from cancer pain to morphine tolerance.
Tu H; Chu H; Guan S; Hao F; Xu N; Zhao Z; Liang Y
Tissue Cell; 2021 Feb; 68():101438. PubMed ID: 33220596
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
20. Mechanism underlying β2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells.
Sharma M; Arbabzada N; Flood PM
J Neuroimmunol; 2019 Jul; 332():37-48. PubMed ID: 30933849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
